Brimonidine Tartrate TCI B6383

Chemical Identity

Other names: 5-Bromo-N-(4,5-dihydro-1H-imidazol-2-yl)quinoxalin-6-amine Tartrate · 5-Bromo-N-(4,5-dihydro-1H-imidazol-2-yl)-6-quinoxalinamine Tartrate · 5-Bromo-N-(4,5-dihydro-1H-imidazol-2-yl)quinoxalin-6-amine (2R
CAS No.: 70359-46-5
PubChem: CID 54405
Formula: C11H10BrN5.C4H6O6
Molecular weight: 442.23 g/mol
Purity: >98.0%(HPLC)(T)
Storage: 0-10°C
Reference databases: ECHA

Full identifiers (IUPAC, SMILES, InChIKey)

IUPAC: 5-bromo-N-(4,5-dihydro-1H-imidazol-2-yl)quinoxalin-6-amine;(2R,3R)-2,3-dihydroxybutanedioic acid
SMILES: C1CN=C(N1)NC2=C(C3=NC=CN=C3C=C2)Br.C(C(C(=O)O)O)(C(=O)O)O
InChIKey: QZHBYNSSDLTCRG-LREBCSMRSA-N
MDL: MDL07773072

Rp 980.700,00

Sale Sold out

Shipping calculated at checkout.

Berat 100mg 1g

Pembayaran hanya melalui request quotation dan dilakukan setelah tim kami menghubungi Anda. Mohon cantumkan nomor WhatsApp aktif untuk konfirmasi pesanan & pembuatan invoice. Estimasi pengiriman 2-4 minggu setelah pembayaran.

Dokumen Keamanan & Mutu

↓ Unduh SDS / MSDS (PDF resmi TCI)

CoA (Certificate of Analysis)

Spesifik per batch produksi — diterbitkan dan dikirim bersama barang sesuai nomor lot yang Anda terima.

Contoh CoA segera tersedia.

💬 Minta CoA via WhatsApp

View full details

TCI B6383 Brimonidine Tartrate (CAS 70359-46-5) is the tartrate salt of a selective α2-adrenergic receptor agonist, offered strictly as a pharmaceutical research reagent for experimental use. The salt form improves aqueous handling, which makes stock solution preparation for binding assays, functional studies, and formulation work more convenient. It is widely used as a reference compound in adrenergic signalling research and as a model substance in analytical method development. Available in 100 mg and 1 g sizes, it should be kept cool, dry, and light-protected, and must never be used for human or veterinary therapeutic purposes.

TCI brochures (PDF)

Pharmaceutical Ingredients for Research and Experimental Use 2026-03-09 · p. 43

Related TCI products

—

Brand	—
CAS number	—
Molecular formula	—
Purity	—
Category	—
Pack sizes	—
Physical form	—
Storage	—

—

(2024). Brimonidine tartrate: risk of serious corneal opacity. Reactions Weekly doi:10.1007/s40278-024-63460-z
Dinç (2017). Continuous Wavelet Transform Methods for the Simultaneous Quantification of Brimonidine Tartrate and Timolol Maleate in an Eye Drop Formulation. Bioequivalence & Bioavailability International Journal doi:10.23880/beba-16000105
Kim (2024). Charles Bonnet Syndrome Precipitated by Brimonidine Tartrate. Journal of Medical Optometry doi:10.62055/xqbniayihzdr

References were compiled automatically from Crossref and every DOI was verified to exist. AMI Scientific is not affiliated with the authors or the publishers.